Common use of Permitted Uses and Disclosures of PHI Clause in Contracts

Permitted Uses and Disclosures of PHI. Unless otherwise limited herein, in addition to any other uses and/or disclosures permitted or required by this BA Agreement or required by law, Boston Scientific may: 3.1. make any and all uses and disclosures of PHI necessary to provide Reimbursement Assistance to Provider; 3.2. use the PHI in its possession for its proper management and administration and to fulfill any legal responsibilities of Boston Scientific; 3.3. disclose the PHI in its possession to a third party for the purpose of Boston Scientific’s proper management and administration or to fulfill any legal responsibilities of Boston Scientific; provided, however, that the disclosures are Required by Law or Boston Scientific has received from the third party written assurances that (i) the information will be held confidentially and used or further disclosed only as Required by Law or for the purpose for which it was disclosed to the third party; and (ii) the third party will notify Boston Scientific of any instances of which it becomes aware in which the confidentiality of the information has been breached; 3.4. perform Data Aggregation for the Health Care Operations of Provider; 3.5. de-identify any and all PHI created or received by Boston Scientific under this BA Agreement; provided, however, that the de-identification conforms to the requirements of the Privacy Rule. Such resulting de-identified information would not be subject to the terms of this BA Agreement; and 3.6. may use the PHI to create Limited Data Sets consistent with the requirements of 45 CFR § 164.514(e)(2) of the Privacy Rule (“LDS”). Boston Scientific may use or disclose the LDS only for the limited purposes of Research, Public Health, or Health Care Operations, and the LDS will include only the minimum data fields necessary to accomplish these limited purposes. Boston Scientific will comply with this BA Agreement with respect to the use and disclosure of the LDS.

Permitted Uses and Disclosures of PHI. Unless otherwise limited herein, in addition to any other uses and/or disclosures permitted or required by this BA Agreement or required by law, Boston Scientific may: 3.1. make any and all uses and disclosures of PHI necessary to provide Reimbursement Assistance to Provider; 3.2. use the PHI in its possession for its proper management and administration and to fulfill any legal responsibilities of Boston Scientific; 3.3. 3.1 disclose the PHI in its possession to a third party for the purpose of Boston Scientific’s proper management and administration or to fulfill any legal responsibilities of Boston Scientific; provided, however, that the disclosures are Required by Law or Boston Scientific has received from the third party written assurances that (i) the information will be held confidentially and used or further disclosed only as Required by Law or for the purpose for which it was disclosed to the third party; and (ii) the third party will notify Boston Scientific of any instances of which it becomes aware in which the confidentiality of the information has been breached; 3.4. 3.2 perform Data Aggregation for the Health Care Operations of ProviderCovered Entity; 3.5. 3.3 de-identify any and all PHI created or received by Boston Scientific under this BA Agreement; provided, however, that the de-identification conforms to the requirements of the Privacy Rule. Such resulting de-identified information would not be subject to the terms of this BA Agreement; and 3.6. 3.4 may use the PHI to create Limited Data Sets consistent with the requirements of 45 CFR § 164.514(e)(2) of the Privacy Rule (“LDS”). Boston Scientific may use or disclose the LDS only for the limited purposes of Research, Public Health, or Health Care Operations, and the LDS will include only the minimum data fields necessary to accomplish these limited purposes. Boston Scientific will comply with this BA Agreement with respect to the use and disclosure of the LDS.